This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Chu-Ya Yang in Central Nervous System Applications
Introduction
Chu-Ya Yang is an accomplished inventor based in Changhua, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the development of materials for use in the central nervous system. His innovative work focuses on creating compositions that can effectively interact with biological systems.
Latest Patents
One of his notable patents is titled "Synthetic diblock copolypeptide hydrogels for use in the central nervous system." This invention relates to a composition suitable for administration to the central nervous system (CNS). It comprises a block copolypeptide hydrogel that includes a biologically active material, either mixed with the hydrogel or attached to the polypeptide chain. The composition is designed for effective administration to the CNS. The patent also discloses methods for making and using these compositions as depots or scaffolds for cell migration, along with pharmaceutical compositions and kits for implementing these methods.
Career Highlights
Chu-Ya Yang is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential applications in treating various neurological conditions.
Collaborations
He has collaborated with notable colleagues, including Michael V. Sofroniew and BingBing Song, who contribute to the interdisciplinary nature of his research.
Conclusion
Chu-Ya Yang's innovative work in synthetic hydrogels represents a significant advancement in the field of biomedical engineering, particularly for applications in the central nervous system. His contributions are paving the way for future developments in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
